← Insider buys

Jeffrey Z Mann has bought stock on 3 days since Jan 2020

Pres, Pharm Svc&Prod Mgmt, CLO at Embecta Corp., and 1 other company

SEC CIK 0001784562 · Filings on SEC.gov ↗

$252KBought
$0Sold
Aug 13Last buy

Jeffrey Z Mann's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

3 filings since Jan 2020, newest first

About Jeffrey Z Mann

Jeffrey Z. Mann is a person and serves as Senior Vice President, General Counsel, Head of Corporate Development, and Secretary at Embecta Corp.( He has been with embecta since April 2022 in a senior legal and business development capacity, after previously serving as Senior Vice President, General Counsel, and Head of Business Development for BD’s Diabetes Care business.(

Mann’s background combines medical device and law firm experience, which embecta says totals 22 years.( Bloomberg also identifies him as having career history and education details on file, and his LinkedIn profile lists Boston College Law School, where he graduated magna cum laude.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.